KML Vision and PreciPoint launch a strategic partnership to provide an end-to-end experience in microscopy imaging and analysis
Bioimage analysis software provider KML Vision GmbH and MedTech company PreciPoint GmbH have embarked upon a joint collaboration initiative. This exciting new partnership will integrate the development, sales, and marketing efforts of both companies, to deliver end-to-end imaging solutions for users in the digital pathology market.
- (1888PressRelease) January 28, 2023 - Together towards a cohesive bioimage acquisition and analysis process
The partnership between the two companies will provide research users in life sciences with complementary microscopy imaging, bioimage analysis, and data management solutions, as an attractive combined product offering. This combined offering addresses the ever-increasing demand from users for solutions that are truly digital, easy-to-use, and comprehensive in terms of covering the whole imaging process. Customers will benefit from streamlined workflows and new possibilities for image analysis offered by combining PreciPoint’s imaging devices and KML Vision’s software solutions.
“In PreciPoint's microscopy products we see an innovative and reliable technology to provide high-quality data for flexible AI-based image analysis using IKOSA. Joining forces creates many opportunities for our customers to smoothly integrate different aspects of their lab workflow using state-of-the-art solutions,” notes KML Vision CEO, Philipp Kainz.
“Teaming up with KML Vision, a highly regarded specialist in its field, reflects our dedication to optimizing all aspects of the lab workflow for our clients. The AI-based image analysis solutions offered by our collaboration partner are very innovative and provide our customers with a significant edge for processing analytical questions and driving research outcomes. From bioimage acquisition to automated data analysis, our clients are now able to experience truly digital workflows for their imaging challenges,” shares PreciPoint CEO, Dominik Gerber.
This set of shared goals orientates both companies to deliver product- and service synergies that expand the digital pathology possibilities for their customers.
Introducing both collaboration partners
About KML Vision https://www.kmlvision.com/
KML Vision develops award-winning microscopy image analysis solutions for the needs of life science research. Powered by the latest Artificial Intelligence technology, their flagship software product, the IKOSA Platform, empowers customers to create their own unique bioimage analysis applications without requiring writing any software code. IKOSA solutions deliver quick, reliable, and reproducible insights into complex life science questions, while supporting more efficiency, flexibility, and precision in research.
About PreciPoint https://precipoint.com/en
PreciPoint, is internationally known for their digital microscopy devices, such as Fritz and M8, providing industry-leading solutions for microscopy imaging, slide acquisition, image streaming, and digital transformation. PreciPoint’s user-centric approach to virtual microscopy removes barriers in histology labs by making workflows easier and more efficient. Their cutting-edge health tech solutions help to digitize and transform laboratory practice by empowering pathologists with new possibilities for digitization, remote and virtual collaboration, as well as for new business models. PreciPoint has its headquarters near Munich, Germany, and is certified according to ISO 13485:2016.
###
space
space